3002.15.00.11/Ranibizumab (Lucentis) Intravitreal Injection/Mexico

Ranibizumab (Lucentis) Intravitreal Injection from Mexico

Ranibizumab is a humanized monoclonal antibody fragment for wet AMD. Classified HTS 3002.15.00.11 as immunological VEGF inhibitor in measured doses.

Duty Rate — Mexico → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Ophthalmic sterile requirements; declare intravitreal use

Ranibizumab (Lucentis) Intravitreal Injection from Mexico — Import Duty Rate | HTS 3002.15.00.11